Open AccessPrediction of death after endovascular thrombectomy in the extended window: a secondary analysis of DEFUSE 3 "
Author(s) -
Philipp Taussky,
Guilherme José Agnoletto,
Ramesh Grandhi,
Matthew Alexander,
Ka-Ho Wong,
Gregory W. Albers,
Adam de Have
Publication year - 2020
Publication title -
journal of neurointerventional surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.652
H-Index - 55
eISSN - 1759-8486
pISSN - 1759-8478
DOI - 10.1136/neurintsurg-2020-016548
Subject(s) - medicine , stroke (engine) , univariate analysis , diabetes mellitus , statin , cohort , inclusion and exclusion criteria , cardiology , multivariate analysis , mechanical engineering , alternative medicine , pathology , engineering , endocrinology
The Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 (DEFUSE 3) clinical trial assessed the use of endovascular thrombectomy (EVT) during the period 6-16 hours after last normal in selected patients. This is a secondary cohort analysis of the DEFUSE 3 data assessing potential predictive variables for mortality in the EVT-treated patients.